JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹2.98 Cr | ₹3.24 Cr | ₹3.92 Cr | ₹3.99 Cr | ₹4.50 Cr |
What is the latest Total Non-Current Liabilities ratio of JENBURKT PHARMACEUTICALS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹2.98 Cr |
Mar2023 | ₹3.24 Cr |
Mar2022 | ₹3.92 Cr |
Mar2021 | ₹3.99 Cr |
Mar2020 | ₹4.50 Cr |
How is Total Non-Current Liabilities of JENBURKT PHARMACEUTICALS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2.98 Cr | -7.82 | |
Mar2023 | ₹3.24 Cr | -17.36 | |
Mar2022 | ₹3.92 Cr | -1.81 | |
Mar2021 | ₹3.99 Cr | -11.44 | |
Mar2020 | ₹4.50 Cr | - |
Compare Total Non-Current Liabilities of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹466.5 Cr | -3% | 6.5% | 46.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,725.0 Cr | 2.5% | 0.2% | 17.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,525.0 Cr | 2.1% | 3.7% | 66.4% | Stock Analytics | |
CIPLA | ₹123,206.0 Cr | 0.9% | 0.1% | 14.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,519.0 Cr | -0.6% | 0.4% | 28.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,927.5 Cr | -0.3% | -2.2% | -0.1% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | -3% |
6.5% |
46.1% |
SENSEX | 0.8% |
3.8% |
8.4% |
You may also like the below Video Courses